ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

100 NSABP Sites May Enroll Patients; Only One Trial Open

July 15, 1994

In Brief: Jennifer Guy ACCC President, Everson President Elect; CTEP Recruits M.D. Anderson’s Parkinson

April 6, 1990

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

Benno Schmidt, 86, Cancer Act Advocate, Chairman Of MSKCC boards, Cancer Panel

October 29, 1999

Gallo Inquiry Complete; NCAB’s AIDS Committee Plans Q&A Session

June 12, 1992